356 related articles for article (PubMed ID: 32448271)
1. A novel risk score model based on eight genes and a nomogram for predicting overall survival of patients with osteosarcoma.
Wu G; Zhang M
BMC Cancer; 2020 May; 20(1):456. PubMed ID: 32448271
[TBL] [Abstract][Full Text] [Related]
2. Establishment of an Autophagy-Related Clinical Prognosis Model for Predicting the Overall Survival of Osteosarcoma.
Li J; Tang X; Du Y; Dong J; Zhao Z; Hu H; Song T; Guo J; Wang Y; Xu T; Shao C; Sheng Y; Xi Y
Biomed Res Int; 2021; 2021():5428425. PubMed ID: 34604383
[TBL] [Abstract][Full Text] [Related]
3. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
[TBL] [Abstract][Full Text] [Related]
4. Importance of CD8 Tex cell-associated gene signatures in the prognosis and immunology of osteosarcoma.
Lu Y; Cao N; Zhao M; Zhang G; Zhang Q; Wang L
Sci Rep; 2024 Apr; 14(1):9769. PubMed ID: 38684858
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Signature of Osteosarcoma Based on 14 Autophagy-Related Genes.
Qi W; Yan Q; Lv M; Song D; Wang X; Tian K
Pathol Oncol Res; 2021; 27():1609782. PubMed ID: 34335109
[No Abstract] [Full Text] [Related]
6. Comprehensive analysis of prognostic tumor microenvironment-related genes in osteosarcoma patients.
Hu C; Liu C; Tian S; Wang Y; Shen R; Rao H; Li J; Yang X; Chen B; Ye L
BMC Cancer; 2020 Aug; 20(1):814. PubMed ID: 32854645
[TBL] [Abstract][Full Text] [Related]
7. A novel stratification framework based on anoikis-related genes for predicting the prognosis in patients with osteosarcoma.
Zhang X; Wen Z; Wang Q; Ren L; Zhao S
Front Immunol; 2023; 14():1199869. PubMed ID: 37575253
[TBL] [Abstract][Full Text] [Related]
8. A risk score model based on endoplasmic reticulum stress related genes for predicting prognostic value of osteosarcoma.
Zhao Y; Gao J; Fan Y; Xu H; Wang Y; Yao P
BMC Musculoskelet Disord; 2023 Jun; 24(1):519. PubMed ID: 37353812
[TBL] [Abstract][Full Text] [Related]
9. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
Front Immunol; 2022; 13():947802. PubMed ID: 36405735
[TBL] [Abstract][Full Text] [Related]
10. A risk signature-based on metastasis-associated genes to predict survival of patients with osteosarcoma.
Shi Y; He R; Zhuang Z; Ren J; Wang Z; Liu Y; Wu J; Jiang S; Wang K
J Cell Biochem; 2020 Jul; 121(7):3479-3490. PubMed ID: 31898371
[TBL] [Abstract][Full Text] [Related]
11. A support vector machine classifier for the prediction of osteosarcoma metastasis with high accuracy.
He Y; Ma J; Ye X
Int J Mol Med; 2017 Nov; 40(5):1357-1364. PubMed ID: 28901446
[TBL] [Abstract][Full Text] [Related]
12. N6-methyladenosine Modification-Related Long Non-Coding RNAs are Potential Biomarkers for Predicting the Prognosis of Patients With Osteosarcoma.
Yang K; Wang F; Li K; Peng G; Yang H; Xu H; Xiang Y; Sun H
Technol Cancer Res Treat; 2022; 21():15330338221085354. PubMed ID: 35422168
[No Abstract] [Full Text] [Related]
13. A potential prognostic prediction model for metastatic osteosarcoma based on bioinformatics analysis.
Wang Y; Ming G; Gao B
Acta Orthop Belg; 2023 Sep; 89(3):373-380. PubMed ID: 37935218
[TBL] [Abstract][Full Text] [Related]
14. A DNA methylation-associated nomogram predicts the overall survival of osteosarcoma.
Shi J; Huang D; Zhang G; Zhao F; Yang L
Medicine (Baltimore); 2020 Dec; 99(51):e23772. PubMed ID: 33371144
[TBL] [Abstract][Full Text] [Related]
15. Expression of immune-related genes as prognostic biomarkers for the assessment of osteosarcoma clinical outcomes.
Guo J; Li X; Shen S; Wu X
Sci Rep; 2021 Dec; 11(1):24123. PubMed ID: 34916564
[TBL] [Abstract][Full Text] [Related]
16. A 21‑gene Support Vector Machine classifier and a 10‑gene risk score system constructed for patients with gastric cancer.
Jiang H; Gu J; Du J; Qi X; Qian C; Fei B
Mol Med Rep; 2020 Jan; 21(1):347-359. PubMed ID: 31939629
[TBL] [Abstract][Full Text] [Related]
17. Ferroptosis-related gene signature associates with immunity and predicts prognosis accurately in patients with osteosarcoma.
Lei T; Qian H; Lei P; Hu Y
Cancer Sci; 2021 Nov; 112(11):4785-4798. PubMed ID: 34506683
[TBL] [Abstract][Full Text] [Related]
18. Identification of TNFRSF1A as a potential biomarker for osteosarcoma.
Zhang Y; Liu K; Wang J
Cancer Biomark; 2024; 39(4):299-312. PubMed ID: 38250759
[TBL] [Abstract][Full Text] [Related]
19. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets.
Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M
Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873
[TBL] [Abstract][Full Text] [Related]
20. Combined analysis of DNA methylation and gene expression profiles of osteosarcoma identified several prognosis signatures.
Tian W; Li Y; Zhang J; Li J; Gao J
Gene; 2018 Apr; 650():7-14. PubMed ID: 29407229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
